Submitted by Anonymous (not verified) on 20 November 2023 - 11:49
Human medicines European public assessment report (EPAR): Fingolimod Mylan, fingolimod, Multiple Sclerosis, Relapsing-Remitting, Date of authorisation: 18/08/2021, Revision: 5, Status: Authorised
Source: